[go: up one dir, main page]

AR046955A1 - Preparacion efervescente de una sustancia basica farmaceuticamente activa - Google Patents

Preparacion efervescente de una sustancia basica farmaceuticamente activa

Info

Publication number
AR046955A1
AR046955A1 ARP040104747A ARP040104747A AR046955A1 AR 046955 A1 AR046955 A1 AR 046955A1 AR P040104747 A ARP040104747 A AR P040104747A AR P040104747 A ARP040104747 A AR P040104747A AR 046955 A1 AR046955 A1 AR 046955A1
Authority
AR
Argentina
Prior art keywords
pharmaceutically active
basic substance
active basic
effective preparation
preparation
Prior art date
Application number
ARP040104747A
Other languages
English (en)
Inventor
Oskar Zelder
Corinna Klopprogge
Hartwig Schroeder
Stefan Haefner
Burkhard Kroeger
Patrick Kiefer
Elmar Heinzle
Christoph Wittmann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of AR046955A1 publication Critical patent/AR046955A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Preparacion efervescente que contiene una composicion efervescente, al menos una sustancia básica farmacéuticamente activa y, opcionalmente, uno o más ingredientes activos adicionales, caracterizada porque evita la alcalinizacion de la orina y con ello una acumulacion aumentada de la sustancia básica farmacéuticamente activa, fármacos que contienen esta preparacion efervescente, procedimientos para su preparacion y su uso.
ARP040104747A 2003-12-19 2004-12-17 Preparacion efervescente de una sustancia basica farmaceuticamente activa AR046955A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz

Publications (1)

Publication Number Publication Date
AR046955A1 true AR046955A1 (es) 2006-01-04

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104747A AR046955A1 (es) 2003-12-19 2004-12-17 Preparacion efervescente de una sustancia basica farmaceuticamente activa

Country Status (16)

Country Link
EP (1) EP1696874A1 (es)
JP (1) JP2007515418A (es)
KR (1) KR20060109492A (es)
CN (1) CN1893920A (es)
AR (1) AR046955A1 (es)
AU (1) AU2004308590A1 (es)
BR (1) BRPI0417796A (es)
CA (1) CA2550342A1 (es)
DE (1) DE10359790A1 (es)
EC (1) ECSP066649A (es)
IL (1) IL176356A0 (es)
MA (1) MA28276A1 (es)
MX (1) MXPA06006658A (es)
NO (1) NO20063327L (es)
WO (1) WO2005063199A1 (es)
ZA (1) ZA200604946B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
WO2010056216A1 (en) * 2008-11-11 2010-05-20 Berko Ilac Ve Kimya San.A.S. Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
RU2547562C2 (ru) * 2009-05-27 2015-04-10 Дасан Медикем Ко., Лтд. Многослойная таблетка, содержащая эффервесцентный слой
WO2013109224A1 (en) * 2012-01-18 2013-07-25 Mahmut Bilgic Pharmaceutical compositions comprising diclofenac
CN104622831B (zh) * 2013-11-06 2018-06-22 江苏豪森药业集团有限公司 一种口服片剂及其制备方法
CN107951034B (zh) * 2017-12-01 2021-03-23 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (en) * 1989-09-01 1991-03-02 Ronald Nash Duvall Effervescent cold or sinus allergy medicine composition having reduced sodium content
CA2084028A1 (en) * 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
WO1995003785A1 (en) * 1993-08-03 1995-02-09 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Also Published As

Publication number Publication date
WO2005063199A1 (de) 2005-07-14
CA2550342A1 (en) 2005-07-14
BRPI0417796A (pt) 2007-03-20
AU2004308590A1 (en) 2005-07-14
EP1696874A1 (de) 2006-09-06
MA28276A1 (fr) 2006-11-01
ZA200604946B (en) 2007-09-26
KR20060109492A (ko) 2006-10-20
IL176356A0 (en) 2006-10-05
JP2007515418A (ja) 2007-06-14
NO20063327L (no) 2006-07-18
MXPA06006658A (es) 2006-08-31
CN1893920A (zh) 2007-01-10
ECSP066649A (es) 2006-10-25
DE10359790A1 (de) 2005-07-21

Similar Documents

Publication Publication Date Title
CR11167A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
BRPI0009956B1 (pt) Composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e betametasona, e, uso da mesma
EA200501586A1 (ru) Фармацевтические продукты
SE0100901D0 (sv) New composition
AR054227A1 (es) Composicion de principios activos
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
ATE354362T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
AR034517A1 (es) Formulacion farmaceutica
PT1560826E (pt) Compostos piridopirimidinona, seus processos de preparacao e composicoes farmaceuticas que os contem
TW200640487A (en) Combination of XOLAIR with immunosuppressive agent
AR021405A1 (es) Composiciones de beta-lactama
BR0112847A (pt) Uso de uma forma de dosagem sólida
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
AR046955A1 (es) Preparacion efervescente de una sustancia basica farmaceuticamente activa
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
CL2004001010A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
DE60121293D1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
ITRM20020119A1 (it) Composizioni contenenti plgf ad uso farmaceutico e cosmetico.
CL2004001009A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
DK1420789T3 (da) Anvendelse af aktivstoffer med my-opioid-receptoragonistisk virkning og opioid-receptorantagonistisk virkning som kombinationslægemidler til cancerbehandling
SE0203817D0 (sv) New composition
UY26510A1 (es) " biblioteca de sustancias, procedimiento para su preparación y el uso de esta biblioteca de sustancias para la investigación de sustancias activas."

Legal Events

Date Code Title Description
FA Abandonment or withdrawal